Skip to content

Public FDA record

Z-0733-2007: Bio-Rad-TOX/See Drug Screen Test (25 tests/box), Catalog number 194-5230; Product is distributed by Bio-R

Recall record Z-0733-2007 for Bio-Rad Laboratories Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0733-2007
Company in FDA record
Bio-Rad Laboratories Inc
FDA classification date
Apr 10, 2007
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The product may produce a faint line which could be interpreted as a false negative test result .

Source facts

Action
The firm intends to contact its subsidiary distributors and sales staff via Fax (Feb 12, 2007) and phone call. In addition, the recall notification will be posted on the firm's intranet site. Customers are instructed to destroy recalled product following standard laboratory practices.
Initiated
2007-02-12
Root cause
Other
Terminated
2008-02-04
Distribution
Worldwide distribution --- USA and countries of Australia and Italy.
Recall number
Z-0733-2007
Recall status
Terminated
CDRH record ID
50588
FDA classified
2007-04-10
Recall event number
37465

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗